The size of gallbladder polyps should guide follow-up strategy, as large lesions at baseline were more likely to progress and become malignant, according to a study published online Aug. 20 in Archives of Surgery.

Researchers have developed a radiosensitivity predictive assay and validated a molecular signature that could lead to improved radiation therapy (RT) decision-making in the treatment of breast cancer patients, according to an article published in Clinical Cancer Research.

High mammographic breast density is a marker of increased risk for developing breast cancer, but, according to research published Aug. 20 in the Journal of the National Cancer Institute, high density does not seem to increase the risk of death among breast cancer patients.

The FDA has granted approval to the University of Texas Health Science Center at Houston (UTHealth) for its coronary flow reserve quantification software, cfrQuant, which will be sold by Positron.

The FDA has made product label changes for GE Healthcare's Optison (perflutren protein-type A microspheres injectable suspension), a contrast agent that can be used to visualize the left ventricular border of the heart during echocardiograms.

The Office of the National Coordinator for Health IT (ONC) has launched a video contest to learn how patients and consumers are using health IT to manage their medications.

While researchers have speculated that changes in brain blood flow due to vein abnormalities contribute to multiple sclerosis (MS) disease severity, a study published online Aug. 21 in Radiology has demonstrated this may not be the case as these abnormalities were shown not to be specific to MS.

W. L. Gore & Associates has received CE Mark for the Gore Hybrid Vascular Graft, which is designed to expand treatment options for outflow by maximizing the number of access sites available.